Polynovo Ltd (PNV)

1.935
+0.035(+1.84%)
  • Volume:
    2,007,196
  • Bid/Ask:
    1.935/1.940
  • Day's Range:
    1.905 - 1.950

PNV Overview

Prev. Close
1.9
Day's Range
1.905-1.95
Revenue
18.1M
Open
1.905
52 wk Range
0.835-2.25
EPS
-0.002
Volume
2,007,196
Market Cap
1.31B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,002,110
P/E Ratio
-784.37
Beta
1.5
1-Year Change
31.53%
Shares Outstanding
677,477,518
Next Earnings Date
Feb 21, 2023
What is your sentiment on Polynovo?
or
Market is currently closed. Voting is open during market hours.

Polynovo Ltd News

Polynovo Ltd Company Profile

Polynovo Ltd Company Profile

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Read More

Analyst Price Target

Average1.980 (+2.326% Upside)
High2.300
Low1.200
Price1.935
No. of Analysts5
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellNeutralStrong Buy
Technical IndicatorsSellSellNeutralStrong SellStrong Buy
SummaryStrong SellStrong SellNeutralSellStrong Buy